Substrate Mapping and Voltage Mapping
When the arrhythmia will not show itself, we read the tissue instead. Voltage tells us where scar lives, where surviving fibers hide, and where a circuit could form.
Sometimes the tachycardia refuses to cooperate. We bring the patient to the EP lab, deliver programmed stimulation, push isoproterenol, and still the VT will not start or sustain long enough to map. Without a stable tachycardia, activation mapping and entrainment are off the table.
Substrate mapping takes a fundamentally different approach. Instead of chasing the arrhythmia in real time, we map the tissue itself to identify where a reentrant circuit could live. The logic is straightforward: scar-related VT requires surviving muscle fibers threaded through dense fibrosis. If we can find those channels and eliminate them, we can prevent the arrhythmia from ever forming, whether or not it appears during the procedure.
Voltage as a Surrogate for Tissue Health
The amplitude of a local bipolar electrogram reflects the density and electrical coupling of myocytes beneath the catheter tip. Healthy myocardium is tightly packed with well-coupled cells. When a depolarization wave sweeps through, the coordinated charge movement produces a tall, sharp signal, typically above 1.5 mV.
Scar tells a different story. Where infarction or fibrosis has replaced muscle, fewer myocytes survive, and those that remain are poorly coupled, separated by collagen. The signal shrinks. In regions of dense scar, the bipolar voltage drops below 0.5 mV or disappears entirely. The catheter records near-silence.
Between these extremes lies the border zone: a patchwork of surviving muscle fibers interspersed with fibrosis. Signals here are reduced (0.5 to 1.5 mV) and often fractionated, reflecting the tortuous, zigzag conduction through surviving bundles. This is precisely the tissue that supports slow conduction and, by extension, reentrant VT.
The Voltage Thresholds
The standard voltage cutoffs for ventricular substrate mapping come from Marchlinski and colleagues:
< 0.5 mV
Electrically silent or near-silent tissue. Most myocytes are dead. Current cannot propagate through these regions.
0.5 – 1.5 mV
Surviving muscle bundles woven through fibrosis. Slow, zigzag conduction. This is where VT channels typically reside.
> 1.5 mV
Healthy, well-coupled myocardium. Tall, sharp electrograms. Rapid, uniform conduction.
These thresholds apply to endocardial ventricular mapping. Atrial tissue produces smaller signals overall, so some groups use lower cutoffs: < 0.5 mV for atrial scar and 0.5 to 1.0 mV for the atrial border zone. The principle is the same; the numbers shift because atrial walls are thinner and contain less muscle mass.
Building the Voltage Map
We construct a voltage map by moving the catheter systematically across the endocardial surface, collecting one data point at a time. At each position, the mapping system records two things: the catheter's three-dimensional coordinates and the local bipolar voltage amplitude. After hundreds or thousands of points, the system reconstructs a 3D shell of the chamber.
Each point is then color-coded by voltage. The conventional palette runs from red or purple (dense scar, < 0.5 mV) through yellow (border zone) to green or teal (normal, > 1.5 mV). The result is a heat map of tissue health. Areas of red immediately show where infarction or fibrosis has destroyed muscle. The yellow fringe around the scar marks the border zone, the hunting ground for VT channels.
Modern multi-electrode catheters (such as the Pentaray or Orion basket) can acquire thousands of points in minutes, creating high-density maps that reveal fine anatomical detail. A single pass across the scar border can resolve channels as narrow as a few millimeters.
Late Potentials and LAVAs
Voltage alone tells us where scar is. The next step is finding the conduction channels hidden within it. Two signal features point directly to surviving fiber bundles conducting slowly through fibrosis.
Late potentials are low-amplitude, high-frequency deflections that persist after the end of the surface QRS complex. In normal tissue, local activation finishes well within the QRS. When signals continue after the QRS ends, they represent muscle bundles so slowly conducting that they are still depolarizing while the rest of the ventricle has already finished. These are the channels a reentrant wavefront can use as its slow limb.
Local abnormal ventricular activities (LAVAs) are fractionated, multi-component signals recorded in the border zone and scar. Where a normal electrogram has a single sharp deflection, a LAVA may show three, four, or more distinct components separated by isoelectric gaps. Each component represents a separate fiber bundle activating at a different time, confirming that conduction through that region is fragmented and slow.
Both late potentials and LAVAs mark tissue that is neither fully dead nor fully alive. These signals are the electrical fingerprint of the substrate that VT needs to survive.
Substrate-Based Ablation Strategies
Once the voltage map and late potential survey are complete, we have a detailed blueprint of the scar architecture. Several strategies exist to eliminate the channels that support VT, all without needing the arrhythmia to be present.
Linear Ablation
We identify the scar isthmus (the narrow corridor of surviving tissue between two regions of dense scar) and draw a line of ablation lesions across it, connecting one scar border to the other. This physically severs the channel the circuit would use.
Scar Homogenization
Rather than targeting one isthmus, we ablate all abnormal signals within the scar. Every late potential, every LAVA, every fractionated electrogram is eliminated. The goal is to convert the entire scar from electrically heterogeneous to electrically silent.
Scar Dechanneling
A more targeted variant: we identify the entrance to each conducting channel by finding the earliest late potential, then ablate at these entry points. By plugging the inlets, we block the circuit without needing to ablate the entire scar.
Each strategy has the same underlying logic: eliminate the slow conduction channels the circuit requires. The choice depends on scar complexity, the number of potential VT morphologies, and the operator's assessment of risk. Scar homogenization is the most aggressive and may reduce VT recurrence most effectively, but it requires more ablation and carries higher procedural risk. Dechanneling is more conservative but demands precise identification of channel entrances.
Epicardial Mapping
Some VT circuits live on the outer surface of the heart, beyond the reach of endocardial catheters. This is common in non-ischemic cardiomyopathy, where fibrosis may be mid-myocardial or epicardial rather than subendocardial. Chagas disease is a classic example: the parasite damages the epicardium preferentially, creating substrate that endocardial mapping cannot see.
To reach the epicardium, we perform subxiphoid pericardial access. A needle is advanced from just below the xiphoid process into the pericardial space, the thin sac surrounding the heart. Once a guidewire is in place, a sheath is introduced, and the mapping catheter can slide freely over the outer surface of the ventricles.
Voltage thresholds on the epicardium differ from the endocardium. Epicardial fat attenuates the electrogram signal, so normal epicardial voltages may be lower than 1.5 mV even in healthy tissue. Some operators use 1.0 mV as the lower bound of normal for epicardial maps. Interpreting the epicardial voltage map therefore requires awareness of local fat thickness, which varies by location (the lateral and inferior walls tend to carry more epicardial fat).
Epicardial ablation carries unique risks: the phrenic nerve runs along the lateral pericardium and can be paralyzed by ablation energy, and coronary arteries course over the epicardial surface. Before delivering energy, we must confirm the catheter is more than 5 mm from any major coronary branch using fluoroscopy or coronary angiography.
A common scenario in clinical practice: the patient has documented VT on a monitor recording, but during the procedure, programmed stimulation cannot reproduce it. The voltage map reveals a large anterior scar with a clear border zone channel. We ablate the channel based on substrate criteria alone.
Six months later, the ICD has not fired once. The VT is gone. We never saw the arrhythmia in the lab, yet the map told us exactly where it lived.
This is the power of substrate mapping. The tissue carries the diagnosis even when the rhythm does not.
Key Takeaways
- Substrate mapping targets the tissue, not the tachycardia. When VT cannot be induced or sustained, we use voltage to locate the anatomical foundation of the circuit.
- Bipolar voltage reflects myocyte density and coupling. Dense scar (< 0.5 mV) is electrically dead. The border zone (0.5 to 1.5 mV) harbors the slow-conducting channels that support reentry. Normal tissue (> 1.5 mV) conducts rapidly and uniformly.
- Late potentials and LAVAs mark the critical channels. Signals persisting after QRS end, or fractionated into multiple components, identify surviving fiber bundles conducting slowly through scar.
- Ablation strategies include linear lesions, scar homogenization, and dechanneling. All aim to eliminate slow conduction channels, differing in aggressiveness and targeting precision.
- Epicardial substrate matters in non-ischemic cardiomyopathy and Chagas disease. Subxiphoid pericardial access allows mapping the outer ventricular surface, but fat attenuation and proximity to coronary arteries and the phrenic nerve add complexity.
- The map carries the diagnosis. Substrate mapping can guide successful ablation even when the clinical arrhythmia never appears during the procedure.